Occupational exposure to antineoplastic agents and parameters for renal dysfunction

Area of Science:

• Occupational Health
• Nephrology
• Pharmacology

Background:

• Antineoplastic agents are used in cancer treatment but can pose risks with occupational exposure.
• Monitoring early renal effects is crucial to assess potential kidney damage from workplace exposures.
• Retinol-binding protein (RBP) and albumin (ALB) are established biomarkers for early kidney dysfunction.

Purpose of the Study:

• To investigate the potential nephrotoxic effects of occupational exposure to antineoplastic agents.
• To assess early renal damage by measuring urinary RBP and ALB levels in exposed hospital workers.

Main Methods:

• Urine samples were collected from 11 hospital workers preparing/administering antineoplastic agents.
• A control group of 23 hospital workers with no drug handling exposure was included.
• Urinary levels of retinol-binding protein (RBP) and albumin (ALB) were measured in both groups.

Main Results:

• No significant differences in urinary RBP and ALB levels were observed between the exposed and nonexposed groups.
• Exposure to cyclophosphamide (CP) and potentially other antineoplastic agents was confirmed in the hospital workers.
• The measured exposure levels did not correlate with detectable early nephrotoxic effects.

Conclusions:

• Current occupational exposure levels to antineoplastic agents in this study did not induce measurable early nephrotoxicity.
• RBP and ALB may not be sensitive enough to detect very early renal changes at these specific exposure levels.
• Further research with larger cohorts or different biomarkers might be warranted to fully understand long-term risks.